Gynecol. Oncol.

Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma.

Huvila J, Laajala TD, Edqvist PH, ..., Aittokallio T, Auranen A

Gynecol. Oncol. 149 (1) 173-180 [2018-04-00; online 2018-03-02]

Adil Mardinoglu Affiliated researcher SciLifeLab Fellow

Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.

Fonnes T, Berg HF, Bredholt T, ..., Tangen IL, Krakstad C

Gynecol. Oncol. 148 (1) 197-203 [2018-01-00; online 2017-10-31]

Affiliated researcher

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.

Edqvist PH, Huvila J, Forsström B, ..., Pontén F, Auranen A

Gynecol. Oncol. 137 (3) 529-537 [2015-06-00; online 2015-04-07]

Affiliated researcher

Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.

Huvila J, Talve L, Carpén O, ..., Grénman S, Auranen A

Gynecol. Oncol. 130 (3) 463-469 [2013-09-00; online 2013-06-15]

Affiliated researcher

Primary high-risk HPV screening for cervical cancer in post-menopausal women.

Gyllensten U, Gustavsson I, Lindell M, Wilander E

Gynecol. Oncol. 125 (2) 343-345 [2012-05-00; online 2012-01-28]

Affiliated researcher